IL17A and acute myeloid leukemia: The frequency of the immunosuppressive IL-17/IL-10-secreting cells in patients, needs more investigations but could represent a novel, simple, prognostic tool to identify the relative risk of severe infections and, perhaps, an increased risk of relapse for AML.